Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 453 results for "sun pharma advanced research"

1 images for "sun pharma advanced research"

Solar Novus Today, 4 weeks ago

R&D expenditure of 25 Indian pharma cos surges by 20.6% in 2013-14

The Research and Development (R&D) spending of 25 leading Indian pharmaceutical companies increased by 20.6 per cent to Rs. 6,103 crore during the year 2013-14 from Rs. 5,060 crore in the previous year. With higher R&D investments, Indian companies ...
 PharmaBiz1 month ago Volumes jump at KNR Constructions counter  Capital Market2 months ago
Livemint.com

Buy Sun Pharma; target of Rs 944: Firstcall Research

Firstcall Research report on Sun Pharmaceutical Sun Pharma Industries Ltd. was established in 1983 with five psychiatry products and a compact manufacturing facility at Vapi, Gujarat. The company started exporting in 1989 to neighboring countries.
 Moneycontrol.com1 month ago SUN PHARMA ADVANCED RESEARCH : Reserch promoter entity fined  4 Traders1 month ago Sebi fines Sun Pharma Advanced Research's promoter entity  Economic Times2 months ago
[x]  

Sensex surges 200 pts; SBI, Arvind most active shares

State Bank of India, Arvind, Sun Pharma Advanced Research, Tata Sponge, Wockhardt, TCS, ONGC and ICICI Bank were most active shares
 Money Control2 months ago

Pick Abbott India on correction: Vishal Jajoo

"If we sees certain correction happening, Abbott India would be my first pick and in the research space we like Sun Pharma Advanced Research Company because this is a stock that has not moved the way it should be moving amongst the other ...
 Moneycontrol.com2 months ago

Buy Sun Pharma Advanced: Mehraboon Irani

Mehraboon Irani, Principal and Head- Pvt Client Group Business at Nirmal Bang Securities is of the view that one can buy Sun Pharma Advanced Research Company.
 Money Control2 months ago
TeleTrader.com

Sunovion Pharmaceuticals Inc. to Present Data for COPD Portfolio and Pipeline at CHEST 2014

The clinical research program investigating SUN-101, delivered via the innovative, proprietary eFlow ® nebulizer system, is an example of Sunovion's commitment to COPD research and demonstrates the value of nebulization to ...
 Morningstar.com1 week ago Sunovion Pharmaceuticals Inc. Announces Dose Ranging Data from Phase 2 Study of SUN-101 (Glycopyrrolate) Inhalation Solution for Treatment of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)  PipelineReview3 days ago SUNOVION PHARMACEUTICALS INC. : Announces Dose Ranging Data from Phase 2 Study of SUN-101 (Glycopyrrolate) Inhalation Solution for Treatment of Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)  4 Traders3 days ago SUNOVION PHARMACEUTICALS INC. : to Present Data for COPD Portfolio and Pipeline at CHEST 2014  4 Traders1 week ago
[x]  

Epic Research Stock Market Special Updates - 29th October 2014

Asian shares advanced to one-month highs on Wednesday, helped by Wall Street which gained on optimism over corporate earnings and prospects the U.S. Federal Reserve will reaffirm its willingness to wait longer before raising interest rates. P { ...
 Press Release Ping2 days ago
Pharmaceutical Executive

Gain Competitive Advantage: Think Like a Navy SEAL

Pharmaceutical professionals, teams, and organizations can succeed at an elite level bytackling the tough mental challenges of Navy SEAL training , writesStan Bernard. Victorious warriors win first in their minds, and then go to war. Defeated ...
 Pharmaceutical Executive1 month ago
Business Standard India

Sensex up more than 100 points; Pharma shares rally

The 30-share Sensex was up 111 points at 26,864 and the 50-share Nifty was up 32 points at 8,024 SI Reporter | Mumbai October 28, 2014 Last Updated at 14:32 IST Benchmark indices have firmed up in late trades led by gains in pharma shares which ...
 Business Standard India3 days ago Nifty ends at 8,090 ahead of F&O expiry, Fed meet outcome  Business Standard India2 days ago Sensex gains 128 points ahead of Fed meet; Ranbaxy up 6%  Business Standard India3 days ago Sensex ends at 27,098 ahead of F&O expiry, Fed meet outcome  Rediff.com2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less